# Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery

Source: https://onco.cc/trials/nct02496065/  
OnCo record `nct02496065` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of Tozuleristide run by Blaze Bioscience Inc., completed.

## Summary

Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery is a phase 1 interventional study registered as NCT02496065 by Blaze Bioscience Inc., with 30 participants enrolled, started 2015-07. Conditions recorded: Tumors, Breast. Interventions recorded: BLZ-100.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT02496065
- Phase: 1
- Setting: A Phase 1 Exploratory Study of the Safety and ex Vivo Fluorescence of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Solid Tumors Undergoing Surgery
- Sponsor: Blaze Bioscience Inc.
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT02496065: https://clinicaltrials.gov/study/NCT02496065

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- drugs: [Tozuleristide](https://onco.cc/drugs/blz-100/)
- companies: [Blaze Bioscience](https://onco.cc/companies/blaze-bioscience/)

---
JSON: https://onco.cc/api/v1/entities/nct02496065.json